Crossmark

Nicotine Replacement Therapy Does Not Reduce Headaches Following Subarachnoid Hemorrhage: A Propensity Score-Matched Study

Published Online: 2022-09-01

Published Print: 2023-02

Authors

Charvet, Aude https://orcid.org/0000-0002-7492-8544
Bouchier, Baptiste

Dailler, Frédéric

Ritzenthaler, Thomas
License Information

Text and Data Mining valid from 2022-09-01

Version of Record valid from 2022-09-01
More Information

Article History

Received: 8 August 2021

Accepted: 26 July 2022

First Online: 1 September 2022

Conflicts of interest

: None.

: The study respects ethical guidelines and was approved by our institutional review board (CPP sud est II, number IRB 00 009 118).

: ClinicalTrials.gov: NCT02890004.

Document is current